These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10817527

  • 1. Moclobemide enhances aversively motivated learning and memory in rats.
    Frank M, Braszko JJ.
    Pol J Pharmacol; 1999; 51(6):497-503. PubMed ID: 10817527
    [Abstract] [Full Text] [Related]

  • 2. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E, Chodera A, Kus K, Rybakowski J.
    Arzneimittelforschung; 1998 Jun; 48(6):625-8. PubMed ID: 9689417
    [Abstract] [Full Text] [Related]

  • 3. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
    Fedosiewicz-Wasiluk M, Hoły ZZ, Wiśniewska RJ, Wiśniewski K.
    Amino Acids; 2005 Feb; 28(1):111-7. PubMed ID: 15700110
    [Abstract] [Full Text] [Related]

  • 4. 2R,4R-APDC influence on hypoxia-induced impairment of learning and memory processes in passive avoidance test.
    Car H, Wiśniewska RJ, Wiśniewski K.
    Pol J Pharmacol; 2004 Feb; 56(5):527-37. PubMed ID: 15591640
    [Abstract] [Full Text] [Related]

  • 5. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D, Bergis OE, Fankhauser C, Gardes A, Adam R, Charieras T, Grosset A, Rovei V, Jarreau FX.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [Abstract] [Full Text] [Related]

  • 6. Reversal of stress-induced memory changes by moclobemide: the role of neurotransmitters.
    Nowakowska E, Chodera A, Kus K, Nowak P, Szkilnik R.
    Pol J Pharmacol; 2001 Apr; 53(3):227-33. PubMed ID: 11785923
    [Abstract] [Full Text] [Related]

  • 7. L-AP4, a potent agonist of group III metabotropic glutamate receptor, decreases central action of angiotensin II.
    Fedosiewicz-Wasiluk M, Hoły ZZ, Wiśniewski K.
    Pol J Pharmacol; 2002 Apr; 54(5):415-22. PubMed ID: 12593528
    [Abstract] [Full Text] [Related]

  • 8. Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV.
    Braszko JJ.
    Peptides; 2004 Jul; 25(7):1195-203. PubMed ID: 15245880
    [Abstract] [Full Text] [Related]

  • 9. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L, Güven O.
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior.
    Borta A, Wöhr M, Schwarting RK.
    Behav Brain Res; 2006 Jan 30; 166(2):271-80. PubMed ID: 16213033
    [Abstract] [Full Text] [Related]

  • 12. AIDA influences behavior in rats pretreated with baclofen.
    Car H, Nadlewska A, Oksztel R, Wiśniewski K.
    Pol J Pharmacol; 2001 Jan 30; 53(3):245-52. PubMed ID: 11785925
    [Abstract] [Full Text] [Related]

  • 13. Effect of vasopressin analog [d(CH2)1(5),Tyr(Me)2]AVP on learning and memory in rats chronically treated with ethanol.
    Car H, Borawska MH, Wiśniewski K.
    Pol J Pharmacol; 1993 Jan 30; 45(5-6):503-12. PubMed ID: 8012473
    [Abstract] [Full Text] [Related]

  • 14. Influence of NMDA, a potent agonist of glutamate receptors, on behavioral activity in 4-week streptozotocin-induced diabetic rats.
    Wiśniewski K, Fedosiewicz-Wasiluk M, Hoły ZZ, Car H, Grzeda E.
    Pol J Pharmacol; 2003 Jan 30; 55(3):345-51. PubMed ID: 14506313
    [Abstract] [Full Text] [Related]

  • 15. Trandolapril attenuates acquisition of conditioned avoidance in rats.
    Braszko JJ, Pasławski L, Karwowska-Polecka W, Hołownia A.
    Pol J Pharmacol; 2000 Jan 30; 52(3):195-201. PubMed ID: 11055576
    [Abstract] [Full Text] [Related]

  • 16. The effects of moclobemide on autonomic and cognitive functions in healthy volunteers.
    Siepmann M, Handel J, Mueck-Weymann M, Kirch W.
    Pharmacopsychiatry; 2004 Mar 30; 37(2):81-7. PubMed ID: 15048616
    [Abstract] [Full Text] [Related]

  • 17. The effect of reversible inactivation of the supramammillary nucleus on passive avoidance learning in rats.
    Shahidi S, Motamedi F, Bakeshloo SA, Taleghani BK.
    Behav Brain Res; 2004 Jun 04; 152(1):81-7. PubMed ID: 15135971
    [Abstract] [Full Text] [Related]

  • 18. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M, Poltyrev T, Bejar C, Youdim MB.
    Psychopharmacology (Berl); 2002 Mar 04; 160(3):318-24. PubMed ID: 11889501
    [Abstract] [Full Text] [Related]

  • 19. D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV.
    Braszko JJ.
    Physiol Behav; 2006 Jun 15; 88(1-2):152-9. PubMed ID: 16690090
    [Abstract] [Full Text] [Related]

  • 20. Effects of stress and of amphetamine on passive avoidance conditioning in rats.
    Trnecková L, Hynie S, Sída P, Hlinák Z, Krejcí I, Klenerová V.
    Gen Physiol Biophys; 2005 Mar 15; 24(1):129-42. PubMed ID: 15900092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.